NN

Namrah Nausher Rogangar

Active Director Director DIN 08748481
DIN 08748481 First appointment May 2020 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2020
Shareholding value •••• Premium profile

About Namrah Nausher Rogangar

Data last updated:

Namrah Nausher Rogangar is a Director at Biofab Pharma Private Limited (since 2020). The company operates in Business Services. Biofab Pharma Private Limited reported revenue of ₹12.9 Lakh (FY 2025).

DIN 08748481
Primary Designation Director
Industry Business Services
First Appointment 28 May 2020
Oldest Company Age 6 yrs
Largest company Biofab Pharma Private Limited · ₹12.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biofab Pharma Private Limited U74999MH2020PTC340062
Director28 May 20202020₹12.9 Lakh (FY 2025)Active

Board colleagues of Namrah Nausher Rogangar

Directorship timeline

Open interactive timeline →
Biofab Pharma Private Limited
Premium access

Shareholding and investment profile for Namrah Nausher Rogangar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Namrah Nausher Rogangar

Namrah Nausher Rogangar currently holds 1 directorship: Biofab Pharma Private Limited (Director, since 28 May 2020, revenue ₹12.9 Lakh (FY 2025)).

Namrah Nausher Rogangar was first appointed on 28 May 2020 as Director at Biofab Pharma Private Limited.

The current boards of Namrah Nausher Rogangar's companies include Mohd Talib Mohd Tahir Usmani (Biofab Pharma Private Limited), Nausherali Rogangar (Biofab Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available